Reko International Group Inc.
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 9.1M | 10.8M | 10.3M | 10.8M | 10.2M | -- |
| Operating Revenue | 9.1M | 10.8M | 10.3M | 10.8M | 10.2M | -- |
| Cost Of Revenue | 7.5M | 9.0M | 8.6M | 9.1M | 8.2M | -- |
| Gross Profit | 1.5M | 1.8M | 1.8M | 1.7M | 2.0M | -- |
| Selling General And Administration | 1.2M | 1.2M | 2.3M | 1.6M | 1.5M | -- |
| Operating Expense | 1.2M | 1.2M | 2.3M | 1.6M | 1.5M | -- |
| Operating Income | 311,000 | 593,000 | -537,000 | 102,000 | 503,000 | -- |
| EBIT | 544,000 | 899,000 | -230,000 | -28,000 | 251,000 | -- |
| Interest Expense | 73,000 | 102,000 | 117,000 | 122,000 | 122,000 | -- |
| Interest Expense Non Operating | 73,000 | 102,000 | 117,000 | 122,000 | 122,000 | -- |
| Interest Income | 116,000 | 138,000 | 132,000 | 128,000 | 115,000 | -- |
| Interest Income Non Operating | 116,000 | 138,000 | 132,000 | 128,000 | 115,000 | -- |
| Net Interest Income | 43,000 | 36,000 | 15,000 | 6,000 | -7,000 | -- |
| Other Income Expense | 117,000 | 168,000 | 175,000 | -258,000 | -367,000 | -- |
| Other Non Operating Income Expenses | 96,000 | 132,000 | 102,000 | 79,000 | 27,000 | -- |
| Special Income Charges | 56,000 | -5,000 | 37,000 | 1,000 | 0.00 | -- |
| Gain On Sale Of Security | -35,000 | 41,000 | 36,000 | -338,000 | -394,000 | -- |
| Pretax Income | 471,000 | 797,000 | -347,000 | -150,000 | 129,000 | -- |
| Tax Provision | 87,000 | -199,000 | 5,000 | -463,000 | 41,000 | -- |
| Tax Effect Of Unusual Items | 3,879 | 5,400 | 10,950 | -50,550 | -125,225 | -- |
| Net Income From Continuing And Discontinued Operation | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| Net Income From Continuing Operation Net Minority Interest | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| Net Income Including Noncontrolling Interests | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| Net Income Common Stockholders | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| Net Income | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| EBITDA | 1.5M | 1.8M | 747,000 | 962,000 | 1.2M | -- |
| Normalized EBITDA | 1.4M | 1.8M | 674,000 | 1.3M | 1.6M | -- |
| Reconciled Depreciation | 920,000 | 903,000 | 977,000 | 990,000 | 996,000 | -- |
| Basic EPS | 0.07 | -- | -0.06 | 0.05 | 0.02 | -- |
| Diluted EPS | 0.07 | -- | -0.06 | 0.05 | 0.02 | -- |
| Basic Average Shares | 5.5M | -- | 5.5M | 5.5M | 5.6M | -- |
| Diluted Average Shares | 5.5M | -- | 5.6M | 5.7M | 5.6M | -- |
| Total Unusual Items | 21,000 | 36,000 | 73,000 | -337,000 | -394,000 | -- |
| Total Unusual Items Excluding Goodwill | 21,000 | 36,000 | 73,000 | -337,000 | -394,000 | -- |
| Tax Rate For Calcs | 0.18 | 0.15 | 0.15 | 0.15 | 0.32 | -- |
| Normalized Income | 366,879 | 965,400 | -414,050 | 599,450 | 356,775 | -- |
| Diluted NI Availto Com Stockholders | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| Gain On Sale Of Ppe | 56,000 | -23,000 | -6,000 | 1,000 | 0.00 | -- |
| Impairment Of Capital Assets | -- | 0.00 | 250,000 | -- | -- | -- |
| Net Income Continuous Operations | 384,000 | 996,000 | -352,000 | 313,000 | 88,000 | -- |
| Net Non Operating Interest Income Expense | 43,000 | 36,000 | 15,000 | 6,000 | -7,000 | -- |
| Other Special Charges | -- | -18,000 | -293,000 | -- | -- | -- |
| Reconciled Cost Of Revenue | 7.5M | 9.0M | 8.6M | 9.1M | 8.2M | -- |
| Total Expenses | 8.7M | 10.2M | 10.9M | 10.7M | 9.7M | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 12.5M | 18.0M | 20.0M | 18.2M | 13.8M | -- |
| Cash Cash Equivalents And Short Term Investments | 12.5M | 18.0M | 20.0M | 18.2M | 13.8M | -- |
| Cash Financial | 12.5M | 18.0M | 20.0M | 18.2M | 13.8M | -- |
| Accounts Receivable | 9.4M | 9.6M | 9.6M | 11.7M | 13.1M | -- |
| Receivables | 9.4M | 9.6M | 9.6M | 11.7M | 13.1M | -- |
| Inventory | 4.4M | 3.7M | 4.0M | 4.3M | 4.2M | -- |
| Other Current Assets | 853,000 | 825,000 | 1.1M | 1.2M | 1.3M | -- |
| Current Assets | 27.2M | 32.1M | 34.6M | 35.4M | 32.4M | -- |
| Gross PPE | 79.6M | 77.2M | 78.4M | 78.2M | 78.1M | -- |
| Accumulated Depreciation | -53.9M | -53.2M | -55.0M | -54.0M | -53.0M | -- |
| Net PPE | 25.7M | 24.0M | 23.4M | 24.1M | 25.0M | -- |
| Total Non Current Assets | 26.4M | 24.8M | 23.4M | 24.2M | 25.0M | -- |
| Total Assets | 53.6M | 56.9M | 58.1M | 59.6M | 57.4M | -- |
| Current Debt | 1.4M | 4.7M | 1.6M | 1.6M | 1.6M | -- |
| Current Debt And Capital Lease Obligation | 1.4M | 4.7M | 1.6M | 1.6M | 1.6M | -- |
| Accounts Payable | -- | 1.0M | -- | -- | -- | 846,000 |
| Payables | -- | 1.0M | -- | -- | -- | 846,000 |
| Payables And Accrued Expenses | 4.2M | 4.7M | 4.7M | 3.3M | 2.8M | -- |
| Current Accrued Expenses | -- | 3.7M | -- | -- | -- | 2.0M |
| Current Deferred Revenue | 489,000 | 35,000 | 2.2M | 3.1M | 1.7M | -- |
| Other Current Liabilities | 46,000 | 18,000 | 138,000 | 1.0M | 447,000 | -- |
| Current Liabilities | 6.2M | 9.4M | 8.6M | 9.1M | 6.5M | -- |
| Long Term Debt | 4.9M | 5.3M | 8.2M | 8.8M | 9.0M | -- |
| Long Term Debt And Capital Lease Obligation | 4.9M | 5.3M | 8.2M | 8.8M | 9.0M | -- |
| Total Non Current Liabilities Net Minority Interest | 4.9M | 5.3M | 8.2M | 8.8M | 9.4M | -- |
| Total Liabilities Net Minority Interest | 11.1M | 14.7M | 16.8M | 17.9M | 15.9M | -- |
| Common Stock | 16.0M | 16.0M | 16.1M | 16.1M | 16.2M | -- |
| Capital Stock | 16.0M | 16.0M | 16.1M | 16.1M | 16.2M | -- |
| Additional Paid In Capital | 794,000 | 848,000 | 828,000 | 850,000 | 889,000 | -- |
| Retained Earnings | 25.7M | 25.4M | 24.4M | 24.7M | 24.4M | -- |
| Common Stock Equity | 42.5M | 42.2M | 41.2M | 41.6M | 41.5M | -- |
| Stockholders Equity | 42.5M | 42.2M | 41.2M | 41.6M | 41.5M | -- |
| Total Equity Gross Minority Interest | 42.5M | 42.2M | 41.2M | 41.6M | 41.5M | -- |
| Total Capitalization | 47.4M | 47.5M | 49.4M | 50.4M | 50.5M | -- |
| Net Tangible Assets | 42.5M | 42.2M | 41.2M | 41.6M | 41.5M | -- |
| Tangible Book Value | 42.5M | 42.2M | 41.2M | 41.6M | 41.5M | -- |
| Working Capital | 21.0M | 22.7M | 26.0M | 26.3M | 25.9M | -- |
| Invested Capital | 48.9M | 52.2M | 51.1M | 52.1M | 52.1M | -- |
| Total Debt | 6.4M | 10.0M | 9.8M | 10.5M | 10.6M | -- |
| Share Issued | 5.5M | 5.5M | 5.5M | 5.5M | 5.6M | -- |
| Ordinary Shares Number | 5.5M | 5.5M | 5.5M | 5.5M | 5.6M | -- |
| Buildings And Improvements | 14.9M | 14.9M | 14.9M | 14.9M | 14.9M | -- |
| Construction In Progress | 4.0M | 2.2M | 128,000 | 230,000 | 174,000 | -- |
| Current Deferred Liabilities | 489,000 | 35,000 | 2.2M | 3.1M | 1.7M | -- |
| Hedging Assets Current | -- | -- | -- | -- | -- | 0.00 |
| Land And Improvements | 661,000 | 661,000 | 661,000 | 661,000 | 661,000 | -- |
| Leases | 922,000 | 922,000 | 905,000 | 880,000 | 869,000 | -- |
| Machinery Furniture Equipment | 59.1M | 58.5M | 61.8M | 61.5M | 61.4M | -- |
| Non Current Deferred Assets | 751,000 | 790,000 | 39,000 | 43,000 | -- | 0.00 |
| Non Current Deferred Liabilities | -- | 0.00 | 0.00 | 0.00 | 420,000 | 379,000 |
| Non Current Deferred Taxes Assets | 751,000 | 790,000 | 39,000 | 43,000 | -- | 0.00 |
| Non Current Deferred Taxes Liabilities | -- | 0.00 | 0.00 | 0.00 | 420,000 | 379,000 |
| Other Current Borrowings | 1.4M | 4.7M | 1.6M | 1.6M | 1.6M | -- |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Work In Process | 4.4M | 3.7M | 4.0M | 4.3M | 4.2M | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 193,000 | 251,000 | 2.2M | 5.0M | 2.9M | -- |
| Cash Flow From Continuing Operating Activities | 193,000 | 251,000 | 2.2M | 5.0M | 2.9M | -- |
| Depreciation And Amortization | 920,000 | 903,000 | 977,000 | 990,000 | 996,000 | -- |
| Depreciation Amortization Depletion | 920,000 | 903,000 | 977,000 | 990,000 | 996,000 | -- |
| Stock Based Compensation | -17,000 | 20,000 | -21,000 | -20,000 | 50,000 | -- |
| Deferred Tax | 87,000 | -199,000 | 3,000 | -462,000 | 41,000 | -- |
| Deferred Income Tax | 87,000 | -199,000 | 3,000 | -462,000 | 41,000 | -- |
| Change In Working Capital | -1.2M | -1.4M | 2.5M | 3.3M | 1.3M | -- |
| Other Non Cash Items | -43,000 | -36,000 | -15,000 | -6,000 | 7,000 | -- |
| Capital Expenditure | -2.7M | -2.4M | -241,000 | -112,000 | -158,000 | -- |
| Purchase Of PPE | -2.7M | -2.4M | -241,000 | -112,000 | -158,000 | -- |
| Net PPE Purchase And Sale | -2.5M | -1.8M | -241,000 | -111,000 | -158,000 | -- |
| Investing Cash Flow | -2.5M | -1.8M | 18,000 | -111,000 | -158,000 | -- |
| Cash Flow From Continuing Investing Activities | -2.5M | -1.8M | 18,000 | -111,000 | -158,000 | -- |
| Repayment Of Debt | -3.1M | -395,000 | -371,000 | -413,000 | -387,000 | -- |
| Net Issuance Payments Of Debt | -3.1M | -395,000 | -371,000 | -413,000 | -387,000 | -- |
| Repurchase Of Capital Stock | -94,000 | -50,000 | -21,000 | -160,000 | -10,000 | -- |
| Net Common Stock Issuance | -94,000 | -50,000 | -21,000 | -160,000 | -10,000 | -- |
| Common Stock Dividend Paid | -- | -- | -- | -- | -- | 0.00 |
| Common Stock Payments | -94,000 | -50,000 | -21,000 | -160,000 | -10,000 | -- |
| Financing Cash Flow | -3.1M | -445,000 | -392,000 | -573,000 | -397,000 | -- |
| Cash Flow From Continuing Financing Activities | -3.1M | -445,000 | -392,000 | -573,000 | -397,000 | -- |
| Changes In Cash | -5.5M | -2.0M | 1.8M | 4.3M | 2.4M | -- |
| Beginning Cash Position | 18.0M | 20.0M | 18.2M | 13.8M | 11.4M | -- |
| End Cash Position | 12.5M | 18.0M | 20.0M | 18.2M | 13.8M | -- |
| Free Cash Flow | -2.5M | -2.1M | 1.9M | 4.9M | 2.8M | -- |
| Asset Impairment Charge | -- | 0.00 | -- | -- | -- | -- |
| Cash Dividends Paid | -- | -- | -- | -- | -- | 0.00 |
| Depreciation | 920,000 | 903,000 | 977,000 | 990,000 | 996,000 | -- |
| Gain Loss On Investment Securities | 28,000 | -120,000 | -897,000 | 588,000 | 404,000 | -- |
| Gain Loss On Sale Of PPE | -56,000 | 23,000 | 6,000 | -1,000 | 0.00 | -- |
| Interest Paid Cfo | -- | -- | -- | 6,000 | -7,000 | -48,000 |
| Interest Received Cfo | 43,000 | 36,000 | -- | -- | -- | -- |
| Long Term Debt Payments | -3.1M | -395,000 | -371,000 | -413,000 | -387,000 | -- |
| Net Foreign Currency Exchange Gain Loss | 27,000 | -10,000 | -273,000 | 269,000 | 24,000 | -- |
| Net Income From Continuing Operations | 384,000 | 996,000 | -351,000 | 312,000 | 88,000 | -- |
| Net Long Term Debt Issuance | -3.1M | -395,000 | -371,000 | -413,000 | -387,000 | -- |
| Net Other Investing Changes | -- | 18,000 | -- | -- | -- | -- |
| Operating Gains Losses | -1,000 | -107,000 | -1.2M | 856,000 | 428,000 | -- |
| Sale Of PPE | 112,000 | 570,000 | 0.00 | 1,000 | 0.00 | -- |